Synthorx Inc. (THOR)

15.93
0.64 4.20
NASDAQ : Health Technology
Prev Close 15.29
Open 15.35
Day Low/High 15.35 / 16.13
52 Wk Low/High 11.00 / 23.53
Volume 27.16K
Avg Volume 77.80K
Exchange NASDAQ
Shares Outstanding 32.34M
Market Cap 493.15M
EPS -18.10
P/E Ratio 1.44
Div & Yield N.A. (N.A)

Ratings Changes To Be Publicly Issued on 6/21/13

Upgrades: ALSN, MARPS Downgrades: BFS, BIG, FBNC, NSU, THOR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Thoratec Is Now Oversold (THOR)

Thoratec Is Now Oversold (THOR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

4 Stocks Dragging The Health Services Industry Downward

4 Stocks Dragging The Health Services Industry Downward

TheStreet Ratings group highlights 4 stocks pushing the health services industry lower today.

THOR Makes Notable Cross Below Critical Moving Average

THOR Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Thoratec Corp. crossed below their 200 day moving average of $35.46, changing hands as low as $35.33 per share.

8 Stocks Climbing Higher on Unusual Volume

8 Stocks Climbing Higher on Unusual Volume

Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Sunshine Heart: A Promising Treatment for Heart Failure Patients

Sunshine Heart: A Promising Treatment for Heart Failure Patients

Sunshine's C-Pulse is a heart-assist device for patients who fall between the cracks of current therapy.

Analysts' Actions: TXN HAL DFS CELG THOR

Analysts' Actions: TXN HAL DFS CELG THOR

Here are today's top research calls.

Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript

7 Hot Stocks on Traders' Radars

7 Hot Stocks on Traders' Radars

Here's a look at how some of the most-searched stocks are trading technically.

Analysts' Actions: CSCO, MMM, CIT, AMGN, S

Analysts' Actions: CSCO, MMM, CIT, AMGN, S

Here are today's top research calls.

Thoratec Stock Gaps Up On Today's Open (THOR)

Thoratec Stock Gaps Up On Today's Open (THOR)

Shares of Thoratec Corporation (Nasdaq:THOR) were gapping up Thursday morning with an open price 15.3% higher than Wednesday's closing price. The stock closed at $30.81 yesterday and opened today's trading at $35.51.

Thoratec's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Thoratec Corporation (THOR): Today's Featured Health Services Loser

Thoratec Corporation (THOR): Today's Featured Health Services Loser

Thoratec Corporation was a leading decliner within the health services industry, falling $1.02 (-3.4%) to $29.44 on heavy volume.

10 Stocks to Watch: Thoratec, JDS Uniphase

10 Stocks to Watch: Thoratec, JDS Uniphase

Thoratec shares are plunging in premarket trading Wednesday after the company gave a mixed full-year outlook.

Thoratec's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q3 2011 Results - Earnings Call Transcript

JDS Uniphase, Thoratec: After-Hours Trading

JDS Uniphase, Thoratec: After-Hours Trading

JDS Uniphase shares surge in late trades after the company beats Wall Street expectations for its fiscal first quarter.

Thoratec Reaches New 52-Week High (THOR)

Thoratec Reaches New 52-Week High (THOR)

Thoratec Corporation (Nasdaq:THOR) hit a new 52-week high Monday as it is currently trading at $37.56, above its previous 52-week high of $37.55 with 353,100 shares traded as of 2:26 p.m. ET. Average volume has been 864,100 shares over the past 30 days.

Thoratec Reaches New 52-Week High (THOR)

Thoratec Reaches New 52-Week High (THOR)

Thoratec Corporation (Nasdaq:THOR) hit a new 52-week high Friday as it is currently trading at $37, above its previous 52-week high of $36.98 with 560,484 shares traded as of 1:50 p.m. ET. Average volume has been 847,900 shares over the past 30 days.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks are setting up to break out and trade higher from current levels.

Thoratec's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Thoratec's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Thoratec Stock Gaps Up On Today's Open (THOR)

Thoratec Stock Gaps Up On Today's Open (THOR)

Shares of Thoratec Corporation (Nasdaq:THOR) were gapping up Monday morning with an open price 14.9% higher than Friday's closing price. The stock closed at $27.42 yesterday and opened today's trading at $31.51.

AT&T, Nokia, Jetblue: Analysts' New Ratings

AT&T, Nokia, Jetblue: Analysts' New Ratings

AT&T downgraded at UBS from Buy to Neutral. Jetblue downgraded at Soleil from Buy to Hold. Nokia upgraded at Morgan Keegan.

Strategic Diagnostics: Small-Cap Winner

Strategic Diagnostics: Small-Cap Winner

TheStreet presents its daily rundown of the winners and losers in the small-cap space

El Paso Electric: Upgrades, Downgrades

El Paso Electric: Upgrades, Downgrades

El Paso Electric is downgraded from Buy to Hold at Jefferies, which said the stock is already pricing in above-average earnings growth potential.

Protecting Your Home, Passive Investing, Technical Outlook

Protecting Your Home, Passive Investing, Technical Outlook

NEW YORK (TheStreet) -- Guests include Richard Soloway, CEO of Napco Security Technologies, Richard Ferri, author of "The Power of Passive Investing" and Gil Morales, managing director at MoKa Investors

10 Health Care Stocks With Up to 30% Upside

10 Health Care Stocks With Up to 30% Upside

These highly-rated large and mid-cap health care companies are growth plays with very strong sentiment among analysts.

Best Growth Companies in Growing Industries

Best Growth Companies in Growing Industries

To make money in stocks, follow broad growth trends, says Cabot Money Management's Dennis Wassung.

4 Dividend Stocks You Never Knew About

If a growth stock doesn't offer a dividend, you may have to take it yourself.

Volatility Spike Likelihood Raises Risk

Through options expiration, wait for the market to prove itself rather than increasing exposure right at resistance.